Neonatal	neonatal	O	O	O	O
pyridoxine	pyridoxine	CHEMICALS	O	OTHERS	I
responsive	responsive	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
isoniazid	isoniazid	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
17-day-old	17-day-old	O	O	O	O
infant	infant	O	O	O	O
on	on	O	O	O	O
isoniazid	isoniazid	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
13	13	O	O	O	O
mg/kg	mg/kg	O	O	O	O
daily	daily	O	O	O	O
from	from	O	O	O	O
birth	birth	O	O	O	O
because	because	O	O	O	O
of	of	O	O	O	O
maternal	maternal	O	O	O	O
tuberculosis	tuberculosis	O	DISEASE	OTHERS	I
was	was	O	O	O	O
admitted	admitted	O	O	O	O
after	after	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
clonic	clonic	O	O	OTHERS	I
fits	fits	O	O	OTHERS	I
.	.	O	O	O	O

No	no	O	O	O	O
underlying	underlying	O	O	O	O
infective	infective	O	O	O	O
or	or	O	O	O	O
biochemical	biochemical	O	O	O	O
cause	cause	O	O	O	O
could	could	O	O	O	O
be	be	O	O	O	O
found	found	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
fits	fits	O	O	OTHERS	I
ceased	ceased	O	O	O	O
within	within	O	O	O	O
4	4	O	O	O	O
hours	hours	O	O	O	O
of	of	O	O	O	O
administering	administering	O	O	O	O
intramuscular	intramuscular	O	O	O	O
pyridoxine	pyridoxine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
suggesting	suggesting	O	O	O	O
an	an	O	O	O	O
aetiology	aetiology	O	O	O	O
of	of	O	O	O	O
pyridoxine	pyridoxine	CHEMICALS	O	OTHERS	I
deficiency	deficiency	O	O	O	O
secondary	secondary	O	O	O	O
to	to	O	O	O	O
isoniazid	isoniazid	CHEMICALS	O	OTHERS	I
medication	medication	O	O	O	O
.	.	O	O	O	O

